How many institutional investors hold TERN?

4 tracked institutional investors disclosed a position in TERN (TERNS PHARMACEUTICALS INC) in their most recent 13F filing.

Who is the largest institutional holder of TERN?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in TERN, valued at $198M.

Where does this TERN ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

TERN — TERNS PHARMACEUTICALS INC

Name: TERNS PHARMACEUTICALS INC (TERN) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About TERNS PHARMACEUTICALS INC (TERN)

TERNS PHARMACEUTICALS INC (TERN) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $198M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in TERN

100

/100

Strong Institutional Accumulation

Added / Increased1

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track TERN

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

TERN Ownership Composition

How TERNS PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

90% of tracked value

Institutions

tracked investors

Total Reported

$416.6M

combined 13F value

Other90.4%
Hedge Funds9.6%

Other(2)

90.4%

Hedge Funds(2)

9.6%

Tracked investors reporting TERN

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	3.7M	$197.6M	0.03%	Mar 31, 2026
Izzy Englander	Millennium Management	3.4M	$178.9M	0.07%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	573.7K	$23.2M	0.03%	Dec 31, 2025
George Soros	Soros Fund Management	321.9K	$17M	0.19%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
3.7M
Value
$197.6M
% Portfolio
0.03%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
3.4M
Value
$178.9M
% Portfolio
0.07%
Steve CohenDec 31, 2025
Point72 Asset Management
Shares
573.7K
Value
$23.2M
% Portfolio
0.03%
George SorosMar 31, 2026
Soros Fund Management
Shares
321.9K
Value
$17M
% Portfolio
0.19%

Recent activity

Investor	Action	Δ %	Current value	Filing date
George Soros	New	—	$17M	May 15, 2026

George Soros
New
$17MMay 15, 2026

Frequently asked questions

How many institutional investors hold TERN?: 4 tracked institutional investors disclosed a position in TERN (TERNS PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of TERN?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in TERN, valued at $198M.
Did institutional ownership of TERN increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited TERN.
Where does this TERN ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.